YuJa, Inc. Expands Learning Management System Capabilities with New Platform Extensions Supporting a Broader LMS Ecosystem
For institutions using D2L Brightspace, this integration eliminates the need for a browser extension in YuJa Panorama. For YuJa Verity, this extension will streamline workflows for first-time users and eliminate the need for browser extensions to access assessments configured to use Verity's Lockdown App. The integration complements YuJa's native API integrations with other leading LMS platforms, including Moodle's Open LMS, Blackboard, and Canvas, providing flexible integration options to support diverse institutional technology ecosystems.
Other key benefits include:
Simplified integration setup for both YuJa Verity and YuJa Panorama across supported LMSs
A streamlined user experience across platforms
Enhanced functionality with advanced workflows beyond typical LTI capabilities
A standardized integration approach that reduces custom technical implementations
"We've been actively working to eliminate barriers and simplify integration for advanced workflows between YuJa's platforms and LMS solutions,' said Nathan Arora, Chief Executive Officer at YuJa, Inc. "These extensions deliver what our clients have been asking for, simplified setup and access to advanced capabilities across their LMS environment, without complex technical requirements."
YuJa continues to expand its integration capabilities with LMS platforms to help ensure educational institutions can seamlessly incorporate YuJa's solutions into their existing digital learning environments.
ABOUT YUJA, INC.
YuJa is a leader in cloud platforms and compliance applications for regulated sector clients including higher-ed, K12, healthcare, and government. We enable enterprises to deliver engaging and compliant media experiences. We have legal headquarters in Delaware with primary offices in Silicon Valley, California, and Toronto, Canada. Learn more at www.yuja.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Jefferies Upgrade Varonis Systems from Hold to Buy, Raises PT to $65
Varonis Systems, Inc. (NASDAQ:VRNS) is one of the Best Cybersecurity Stocks to Buy Under $100. On July 24, Jefferies upgraded Varonis Systems, Inc. (NASDAQ:VRNS) stock from Hold to Buy, raising its price target from $50 to $65. Joseph Gallo from Jefferies raised the rating and price target on VRNS as the analysts believe cybersecurity spend will remain robust and continue to hold a steady percentage of software budgets in the coming years. Varonis Systems offers small-cap exposure to AI in the space. During Q2 2025, the company saw a notable increase in SaaS revenue, growing significantly to $105.9 million from $44.8 million year-over-year. VRNS remains one of Gallo's favorite stocks for the second half of 2025. welcomia/ Gallo also pointed out that Varonis is well-positioned to address the increasingly important data governance market as generative AI adoption materializes. The SaaS revenue growth during Q2 is a major indicator of where the company is heading. Varonis Systems, Inc. (NASDAQ:VRNS) is a data security company that offers a cloud-native data security platform. The company's system discovers and classifies critical data, removes exposures, and detects advanced threats with AI-powered automation. While we acknowledge the potential of VRNS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
38 minutes ago
- Associated Press
Federal District Court Issues Order Regarding Allied Gaming & Entertainment Combined 2024/2025 Annual Meeting of Stockholders to Take Place As Planned on August 4th, 2025
NEW YORK--(BUSINESS WIRE)--Aug 1, 2025-- Allied Gaming & Entertainment, Inc. (NASDAQ: AGAE) (the 'Company' or 'Allied'), a global experiential entertainment company, announced that the United States District Court for the Central District of California issued an order today that the Combined 2024/2025 Annual Meeting of Stockholders ('Annual Meeting') not be postponed and enjoining Allied and Knighted Pastures LLC ('Knighted') from conducting any vote regarding changes to the composition of Allied's Board of Directors at the Annual Meeting. As such, the Annual Meeting will take place as planned on August 4, 2025, but no vote will be taken on any of the Company's or Knighted's director nominees or Knighted's proposal to remove Mr. Yangyang Li from the board of directors. All other proposals will continue to be voted on at the Annual Meeting. The Company encourages stockholders to vote their proxy card today 'FOR' the Company's proposals. Stockholders may vote electronically or by telephone until 11:59 p.m. eastern time on August 3, 2025, and may also vote at the meeting. About Allied Gaming & Entertainment Allied Gaming & Entertainment Inc. (Nasdaq: AGAE) is a global experiential entertainment company focused on providing a growing world of gamers and concertgoers with unique experiences through renowned assets, products and services. For more information, visit Forward Looking Statements This communication contains certain forward-looking statements under federal securities laws. In some cases, you can identify forward-looking statements by terminology such as 'may,' 'will,' 'should,' 'expect,' 'plan,' 'anticipate,' 'believe,' 'estimate,' 'predict,' 'potential,' 'intend' or 'continue,' the negative of such terms, or other comparable terminology. These statements are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause actual results to be materially different from those contemplated by the forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside our control, that could cause actual results or outcomes to differ materially from those discussed in these forward-looking statements. The inclusion of such information should not be regarded as a representation by the Company, or any person, that the objectives of the Company will be achieved. View source version on CONTACT: Investor Contact: Addo Investor Relations [email protected] KEYWORD: NEW YORK UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: PROFESSIONAL SERVICES ENTERTAINMENT BUSINESS OTHER ENTERTAINMENT EVENTS/CONCERTS ELECTRONIC GAMES SOURCE: Allied Gaming & Entertainment, Inc. Copyright Business Wire 2025. PUB: 08/01/2025 10:20 PM/DISC: 08/01/2025 10:19 PM
Yahoo
42 minutes ago
- Yahoo
3 Penny Stocks With Market Caps Larger Than $10M To Watch
As major U.S. indexes continue their upward trajectory, buoyed by strong corporate earnings and resilient economic data, investors are exploring various avenues for potential growth. Penny stocks, though an older term in the investment lexicon, remain relevant as a category that encompasses smaller or newer companies with lower price points. When these stocks are backed by robust financials and solid fundamentals, they can present unique opportunities for growth that might be overlooked in more traditional investment sectors. Top 10 Penny Stocks In The United States Name Share Price Market Cap Financial Health Rating Waterdrop (WDH) $1.66 $640.14M ★★★★★★ CuriosityStream (CURI) $4.59 $259.69M ★★★★★★ WM Technology (MAPS) $0.9048 $157.25M ★★★★★★ Tuniu (TOUR) $0.9326 $96.34M ★★★★★★ Cardno (COLD.F) $0.1701 $6.64M ★★★★★★ BAB (BABB) $0.8906 $6.51M ★★★★★★ Lifetime Brands (LCUT) $4.44 $103.55M ★★★★★☆ Resources Connection (RGP) $4.98 $169.03M ★★★★★★ TETRA Technologies (TTI) $3.91 $508.34M ★★★★★★ Tandy Leather Factory (TLF) $3.45 $30.22M ★★★★★★ Click here to see the full list of 413 stocks from our US Penny Stocks screener. Here's a peek at a few of the choices from the screener. MediciNova Simply Wall St Financial Health Rating: ★★★★★★ Overview: MediciNova, Inc. is a biopharmaceutical company that develops novel small molecule therapeutics for serious diseases with unmet medical needs in the United States, with a market cap of $65.23 million. Operations: MediciNova, Inc. currently does not report any revenue segments. Market Cap: $65.23M MediciNova, Inc., a pre-revenue biopharmaceutical company with a market cap of US$65.23 million, is advancing its clinical pipeline despite financial challenges. The company remains debt-free and has sufficient cash runway for over three years. Recent updates highlight nearing completion of key trials for MN-166 and MN-001, targeting serious diseases like ALS and fatty liver disease. Although unprofitable with net losses reported at US$2.86 million in Q1 2025, MediciNova's seasoned management and board offer stability as it navigates the volatile penny stock landscape while holding Orphan Drug Designations for several treatments from the FDA and EU EMA. Click here and access our complete financial health analysis report to understand the dynamics of MediciNova. Understand MediciNova's earnings outlook by examining our growth report. Vasta Platform Simply Wall St Financial Health Rating: ★★★★★★ Overview: Vasta Platform Limited offers educational printed and digital solutions to private schools in Brazil's K-12 sector, with a market cap of $330.47 million. Operations: The company generates revenue through its Educational Services segment, specifically in Education & Training Services, amounting to R$1.64 billion. Market Cap: $330.47M Vasta Platform Limited, with a market cap of $330.47 million, operates in Brazil's K-12 educational sector and has recently become profitable, though its earnings are forecast to decline by an average of 55.2% annually over the next three years. Trading at a value below its estimated fair value and compared to peers, Vasta's financial health is supported by satisfactory debt levels and interest coverage. However, recent results show a net loss of R$3.27 million for Q1 2025 against revenue declines from the previous year. Management experience remains unclear while one-off gains have impacted past earnings quality. Unlock comprehensive insights into our analysis of Vasta Platform stock in this financial health report. Gain insights into Vasta Platform's future direction by reviewing our growth report. Hugoton Royalty Trust Simply Wall St Financial Health Rating: ★★★★★★ Overview: Hugoton Royalty Trust operates as an express trust in the United States with a market cap of $14.40 million. Operations: The trust's revenue is derived from its Oil & Gas - Exploration & Production segment, totaling $0.01 million. Market Cap: $14.4M Hugoton Royalty Trust, with a market cap of US$14.40 million, operates in the oil and gas sector but remains pre-revenue with earnings for Q1 2025 at just US$2,407. The trust is unprofitable yet has managed to reduce losses over five years by 28.4% annually. Despite its debt-free status and stable shareholder base without recent dilution, the stock's high volatility poses risks for investors. Recent changes include appointing Grant Thornton LLP as the new auditor after dismissing PwC and experiencing delays in SEC filings, reflecting potential operational challenges amidst an already unstable financial position. Jump into the full analysis health report here for a deeper understanding of Hugoton Royalty Trust. Understand Hugoton Royalty Trust's track record by examining our performance history report. Make It Happen Navigate through the entire inventory of 413 US Penny Stocks here. Want To Explore Some Alternatives? The end of cancer? These 25 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include MNOV VSTA and HGTX.U. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
